Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment.

Borekci S., Atahan E., Yilmaz D. D., Mazican N., Duman B., Ozguler Y., ...Daha Fazla

Respiration; international review of thoracic diseases, cilt.90, sa.3, ss.191-8, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 90 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1159/000434684
  • Dergi Adı: Respiration; international review of thoracic diseases
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.191-8
  • Anahtar Kelimeler: Tumor necrosis factor-alpha inhibitors, Tuberculosis, Risk factors, RHEUMATOID-ARTHRITIS, PULMONARY TUBERCULOSIS, FACTOR ANTAGONISTS, FACTOR INHIBITORS, THERAPY, TNF, AGENTS, SURVEILLANCE, INFLIXIMAB, DISEASES
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: Tumor necrosis factor (TNF)-alpha inhibitors are known to increase the risk of tuberculosis (TB). Objectives: To examine the factors associated with an increased risk of TB in patients receiving anti-TNF-alpha treatment (aTNF-alpha-T).